Stocks
NPSNDNPSND
YHDHealthcareBiotechnology
A contingent value right issued to former shareholders of NPS Pharmaceuticals following its 2015 acquisition by Shire, tied to future sales milestones for the parathyroid hormone therapy Natpara. The security trades over-the-counter and represents a potential payout if specified revenue thresholds a...
Congressional Interest in NPSND (NPSND)
1 member of Congress has disclosed 1 trade in NPSND (NPSND), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading NPSND?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-08 | Shelley M Capito | buy | $1K – $15K |